Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol 2019; 00: 128 (doi:10.1093/annonc/mdz173) Supplementary material was erroneously uploaded for this paper but the file was not intended for publication. This has now been removed. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of OncologyVol. 30Issue 8PreviewIn 2018, the predicted number of new breast cancers in 28 European Union (EU) countries was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 000 and mortality of 32.9/100 000, with 98 755 predicted deaths [1]. Worldwide, there was about 2.1 million newly diagnosed female breast cancer cases in 2018, accounting for almost one in four cancer cases among women, and ∼630 000 died of it [2]. Breast cancer incidence has increased since the introduction of mammography screening and continues to grow with the ageing of the population. Full-Text PDF Open Archive